{{Rsnum
|rsid=8176318
|Gene=BRCA1
|Chromosome=17
|position=43045257
|Orientation=minus
|GMAF=0.2906
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Gene_s=BRCA1
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 44.2 | 45.1 | 10.6
| HCB | 46.3 | 41.2 | 12.5
| JPT | 52.2 | 39.8 | 8.0
| YRI | 76.9 | 21.8 | 1.4
| ASW | 63.2 | 36.8 | 0.0
| CHB | 46.3 | 41.2 | 12.5
| CHD | 29.4 | 54.1 | 16.5
| GIH | 29.7 | 49.5 | 20.8
| LWK | 83.6 | 14.5 | 1.8
| MEX | 57.9 | 35.1 | 7.0
| MKK | 73.1 | 24.4 | 2.6
| TSI | 41.2 | 48.0 | 10.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=21191178
|Title=Rare BRCA1 haplotypes including 3'UTR SNPs associated with breast cancer risk
|OA=1
}}

{{PMID Auto
|PMID=17332845
|Title=Meta-analysis in genome-wide association datasets: strategies and application in Parkinson disease.
|OA=1
}}

{{PMID Auto
|PMID=21161372
|Title=Risk of contralateral breast cancer associated with common variants in BRCA1 and BRCA2: potential modifying effect of BRCA1/BRCA2 mutation carrier status.
|OA=1
}}

{{PMID Auto
|PMID=24915755
|Title=A germline mutation in the BRCA1 3'UTR predicts Stage IV breast cancer
}}
{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}